HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ling Lin Selected Research

VX 702

1/2021Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ling Lin Research Topics

Disease

79Neoplasms (Cancer)
02/2022 - 02/2005
42Narcolepsy
01/2021 - 06/2002
29Inflammation (Inflammations)
07/2022 - 02/2004
20Neoplasm Metastasis (Metastasis)
01/2022 - 04/2010
18Cataplexy
11/2015 - 11/2006
17Breast Neoplasms (Breast Cancer)
08/2021 - 04/2010
16Hepatocellular Carcinoma (Hepatoma)
01/2022 - 05/2003
10Infections
01/2022 - 10/2014
10Atherosclerosis
08/2020 - 05/2009
9Sleep Wake Disorders
10/2020 - 12/2003
8Thrombosis (Thrombus)
11/2019 - 09/2007
7Hypoxia (Hypoxemia)
04/2022 - 05/2009
7Fibrosis (Cirrhosis)
11/2021 - 03/2008
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 03/2015
7Insulin Resistance
01/2021 - 08/2007
7Body Weight (Weight, Body)
01/2021 - 11/2005
7Lung Neoplasms (Lung Cancer)
08/2020 - 01/2013
6Carcinogenesis
01/2022 - 08/2008
6Carcinoma (Carcinomatosis)
01/2022 - 03/2011
6Myocardial Infarction
11/2021 - 08/2005
6Glioma (Gliomas)
11/2021 - 08/2008
6Massive Hepatic Necrosis
08/2021 - 07/2014
6Adenocarcinoma of Lung
11/2020 - 12/2007
6Human Influenza (Influenza)
10/2020 - 10/2013
6Lung Injury
01/2018 - 07/2009
6Parkinson Disease (Parkinson's Disease)
02/2014 - 07/2005
6Disorders of Excessive Somnolence (Hypersomnia)
12/2013 - 05/2003
5Wounds and Injuries (Trauma)
07/2022 - 01/2017
5Alzheimer Disease (Alzheimer's Disease)
10/2021 - 02/2002
5COVID-19
01/2021 - 03/2020
5Sleep Apnea Syndromes (Sleep Apnea)
11/2020 - 12/2004
5Necrosis
01/2020 - 05/2011
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2018 - 07/2014
5Hepatitis
06/2017 - 10/2014
5Sleepiness
11/2015 - 05/2003
4Autoimmune Diseases (Autoimmune Disease)
07/2020 - 02/2004
4Stomach Neoplasms (Stomach Cancer)
01/2019 - 02/2002
3Coronary Artery Disease (Coronary Atherosclerosis)
08/2022 - 08/2013
3Dyslipidemias (Dyslipidemia)
06/2022 - 10/2016
3Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2014
3Liver Failure
01/2022 - 01/2017
3Cardiovascular Diseases (Cardiovascular Disease)
09/2021 - 03/2014

Drug/Important Bio-Agent (IBA)

43Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2003
34OrexinsIBA
01/2021 - 06/2002
18Biomarkers (Surrogate Marker)IBA
11/2022 - 01/2014
17Pharmaceutical PreparationsIBA
02/2022 - 01/2013
10CytokinesIBA
11/2021 - 02/2004
10HLA-DQB1 antigen (HLA DQB1)IBA
11/2015 - 06/2006
9LipopolysaccharidesIBA
08/2021 - 01/2013
9HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 01/2007
8Glucose (Dextrose)FDA LinkGeneric
06/2022 - 10/2010
8MicroRNAs (MicroRNA)IBA
01/2022 - 09/2011
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 10/2006
8AntigensIBA
12/2020 - 03/2007
8LipidsIBA
01/2020 - 01/2014
7Biological ProductsIBA
01/2022 - 04/2003
7Apolipoproteins E (ApoE)IBA
12/2020 - 07/2012
7AutoantibodiesIBA
01/2019 - 02/2004
7Small Interfering RNA (siRNA)IBA
12/2017 - 03/2011
7DNA (Deoxyribonucleic Acid)IBA
11/2015 - 12/2007
6AntibodiesIBA
08/2022 - 08/2009
6Therapeutic UsesIBA
01/2022 - 08/2007
6RNA (Ribonucleic Acid)IBA
02/2021 - 10/2019
6Triglycerides (Triacylglycerol)IBA
01/2021 - 02/2011
6Messenger RNA (mRNA)IBA
01/2020 - 04/2012
5Insulin (Novolin)FDA Link
06/2022 - 09/2010
5C-Reactive ProteinIBA
12/2021 - 08/2006
5Peptides (Polypeptides)IBA
10/2021 - 04/2012
5Amyloid (Amyloid Fibrils)IBA
10/2021 - 02/2002
5GalactosamineIBA
08/2021 - 07/2014
5pandemrixIBA
01/2021 - 01/2017
5EnzymesIBA
01/2020 - 01/2011
5Tissue Plasminogen Activator (Alteplase)FDA Link
10/2017 - 03/2008
5HLA-DRB1 Chains (HLA DRB1)IBA
11/2008 - 01/2004
4LigandsIBA
01/2022 - 01/2012
4SpectrinIBA
01/2022 - 11/2014
4Long Noncoding RNAIBA
10/2021 - 03/2015
4ApolipoproteinsIBA
10/2021 - 07/2012
4Caspase 3 (Caspase-3)IBA
10/2021 - 08/2007
4Intravenous Immunoglobulins (IVIG)FDA Link
01/2021 - 03/2020
4Phosphotransferases (Kinase)IBA
01/2021 - 01/2019
4Estrogen ReceptorsIBA
01/2021 - 01/2020
4Circular RNAIBA
01/2021 - 11/2019
4CholesterolIBA
01/2021 - 01/2011
4ProteomeIBA
01/2021 - 03/2015
4LDL CholesterolIBA
11/2019 - 06/2015
4AMP-Activated Protein KinasesIBA
01/2018 - 04/2015
4Peptide Hydrolases (Proteases)FDA Link
10/2017 - 08/2007
3Oxygen (Dioxygen)IBA
11/2022 - 05/2009
3HydrogelsIBA
07/2022 - 03/2020
3theanineIBA
07/2022 - 01/2020
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 10/2014
3Hemoglobins (Hemoglobin)IBA
04/2021 - 01/2011

Therapy/Procedure

38Therapeutics
01/2022 - 07/2004
7Drug Therapy (Chemotherapy)
01/2021 - 04/2013
6Transplantation
02/2022 - 01/2007
5Stents
11/2014 - 04/2013
4Radiotherapy
01/2022 - 09/2016
4Immunotherapy
01/2021 - 04/2017
4Inlays (Inlay)
05/2018 - 07/2015